Instituto nacional de Cardiologia Ignacio Chavez
Mexico City 14080
4 studies enrolling now · 14 studies all time
What they study most
Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Cardiovascular Diseases, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Elevated Lp(a), Focal Segmental Glomerulosclerosis, Heart Failure, Hypertension, Lupus Nephritis, Percutaneous Coronary Intervention, Pulmonary Arterial Hypertension
Studies at this site
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
- Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
- Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
- Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
- Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
- A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease — Completed
- An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
- Study of Ambrisentan in Participants With Pulmonary Hypertension — Completed
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
- A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed
- Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) — Stopped early